companydirectorylist.com  Global Business Directory e directory aziendali
Ricerca Società , Società , Industria :


elenchi dei paesi
USA Azienda Directories
Canada Business Elenchi
Australia Directories
Francia Impresa di elenchi
Italy Azienda Elenchi
Spagna Azienda Directories
Svizzera affari Elenchi
Austria Società Elenchi
Belgio Directories
Hong Kong Azienda Elenchi
Cina Business Elenchi
Taiwan Società Elenchi
Emirati Arabi Uniti Società Elenchi


settore Cataloghi
USA Industria Directories












France-VZ-VZ Azienda Directories

Liste d'affari ed elenchi di società:
V Z Communication
Indirizzo commerciale:  Chemin des Dimes,60800 Séry Magneval,,France
CAP:  
Numero di telefono :  
Numero di Fax :  
Chiama Numero Verde :  
Numero di cellulare:  
Sito web:  
Email:  
incassi delle vendite:  
Numero dei dipendenti:  
Credit report:  
Persona di contatto:  

Show 1-1 record,Total 1 record










Azienda News:
  • Nonalcoholic Steatohepatitis (NASH) - American Liver Foundation
    NASH: Definition Prevalence NASH (now called MASH) is a dangerously progressive form of NAFLD in which patients have inflammation of the liver and liver damage, in addition to excess fat About 1 5% to 6 5% of U S adults have NASH One estimate is that nine to 15 million adults have NASH NASH prevalence is projected to increase by 63% by
  • NASH: Symptoms, causes, treatment, and more - Medical News Today
    NASH is a potentially serious form of liver disease that develops in people who drink little or no alcohol The acronym stands for “nonalcoholic steatohepatitis ”
  • Nonalcoholic Steatohepatitis (NASH) - StatPearls - NCBI Bookshelf
    Nonalcoholic, fatty liver disease (NAFLD) is defined as the ectopic accumulation of fat in the liver (hepatic steatosis) when no other causes of secondary liver fat accumulation are present Although, minor deposition of fat can occur in the liver of healthy adults, deposition of fat in at least 5% of hepatocytes is considered pathologic NAFLD includes both nonalcoholic fatty liver (NAFL) and
  • Nonalcoholic Fatty Liver Disease (NAFLD) NASH - NIDDK
    Definition Facts Nonalcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in your liver Nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH) are types of NAFLD If you have NASH, you have inflammation and liver damage, along with fat in your liver
  • NASH Overview: Causes, Symptoms, Diagnosis, and Treatment - Pfizer
    NASH and Genetics Genetics seem to contribute to NAFLD and NASH Research has identified gene changes that might play a role, including a certain variation in the PNPLA3 gene 8 This gene gives cells instructions for making adiponutrin, a protein found in liver cells and fat cells 9 Scientists believe that a particular change in the PNPLA3 gene could cause increased fat production and
  • What is NASH? - NASH Disease
    NASH stands for Non-Alcoholic SteatoHepatitis It can be defined as the liver manifestation of a metabolic disorder, and is the most severe form of non-alcoholic fatty liver disease (NAFLD) NASH is closely related to the triple epidemic of obesity, pre-diabetes,
  • Non-alcoholic Steatohepatitis (NASH) - Cedars-Sinai
    Non-alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease (NAFLD) NAFLD is caused by buildup of fat in the liver When this buildup causes inflammation and damage, it is known as NASH, which can lead to scarring of the liver Scarring of the liver is a potentially life-threatening condition called cirrhosis
  • Metabolic Dysfunction-Associated Steatohepatitis (MASH) - Cleveland Clinic
    This condition was previously known as nonalcoholic steatohepatitis (NASH) Without treatment, MASH can lead to conditions like cirrhosis and liver cancer Advertisement Cleveland Clinic is a non-profit academic medical center Advertising on our site helps support our mission We do not endorse non-Cleveland Clinic products or services
  • Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and . . .
    NASH is typically characterized by liver steatosis inflammation, and fibrosis driven by metabolic disruptions such as obesity, diabetes, and dyslipidemia NASH patients with significant fibrosis have increased risk of developing cirrhosis and liver failure Currently, NASH is the second leading cause for liver transplant in the United States




Annuari commerciali , directory aziendali
Annuari commerciali , directory aziendali copyright ©2005-2012 
disclaimer